Total Payments
$703,353
2024 Payments
$366,331
Companies
47
Transactions
1,759
Medicare Patients
4,750
Medicare Billing
$620,197
Payment Breakdown by Category
Other$513,206 (73.0%)
Consulting$90,389 (12.9%)
Travel$58,797 (8.4%)
Food & Beverage$37,594 (5.3%)
Research$2,500 (0.4%)
Education$866.60 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $504,904 | 173 | 71.8% |
| Consulting Fee | $90,389 | 55 | 12.9% |
| Travel and Lodging | $58,797 | 220 | 8.4% |
| Food and Beverage | $37,594 | 1,290 | 5.3% |
| Honoraria | $8,302 | 7 | 1.2% |
| Unspecified | $2,500 | 1 | 0.4% |
| Education | $866.60 | 13 | 0.1% |
Payments by Type
General
$700,853
1,758 transactions
Research
$2,500
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $326,277 | 556 | $0 (2024) |
| Galderma Laboratories, L.P. | $78,618 | 161 | $0 (2024) |
| GENZYME CORPORATION | $76,837 | 108 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $48,326 | 71 | $0 (2024) |
| LEO Pharma Inc. | $38,308 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37,087 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $22,330 | 96 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $17,694 | 38 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $15,322 | 36 | $0 (2024) |
| PFIZER INC. | $10,171 | 93 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $366,331 | 534 | ABBVIE INC. ($110,983) |
| 2023 | $171,067 | 425 | AbbVie Inc. ($85,805) |
| 2022 | $99,436 | 301 | ABBVIE INC. ($90,011) |
| 2021 | $45,055 | 224 | AbbVie Inc. ($27,978) |
| 2020 | $17,338 | 172 | AbbVie Inc. ($10,826) |
| 2019 | $3,713 | 98 | AbbVie, Inc. ($673.48) |
| 2018 | $413.39 | 5 | PFIZER INC. ($167.68) |
All Payment Transactions
1,759 individual payment records from CMS Open Payments — Page 1 of 71
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $12.66 | General |
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Dermatology | ||||||
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.24 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Consulting Fee | Cash or cash equivalent | $1,520.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | Cash or cash equivalent | $26.93 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: Immunology | ||||||
| 12/17/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: Inflammation & Immunology | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,040.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,940.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: ACNE | ||||||
| 12/16/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: ACNE | ||||||
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $30.11 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,240.00 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.26 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,765 | 3,667 | $531,417 | $218,992 |
| 2022 | 12 | 1,067 | 2,209 | $309,191 | $129,778 |
| 2021 | 17 | 1,018 | 2,079 | $341,595 | $148,887 |
| 2020 | 17 | 900 | 1,667 | $316,809 | $122,540 |
Total Patients
4,750
Total Services
9,622
Medicare Billing
$620,197
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 325 | 606 | $118,170 | $55,796 | 47.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 240 | 352 | $61,600 | $30,706 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 258 | 449 | $74,085 | $30,290 | 40.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 86 | 157 | $58,875 | $20,650 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 154 | 154 | $39,270 | $17,055 | 43.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 122 | 146 | $30,660 | $9,964 | 32.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 191 | 275 | $31,625 | $9,275 | 29.3% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 12 | 13 | $13,570 | $6,469 | 47.7% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 13 | 21 | $13,230 | $6,438 | 48.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 151 | 1,238 | $24,760 | $6,206 | 25.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 81 | 81 | $15,795 | $6,034 | 38.2% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $9,375 | $4,836 | 51.6% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 13 | 21 | $7,980 | $4,816 | 60.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 32 | 44 | $16,500 | $4,388 | 26.6% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 14 | 15 | $5,250 | $2,587 | 49.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 12 | 13 | $5,746 | $1,485 | 25.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 26 | $2,400 | $1,070 | 44.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 21 | $2,406 | $909.84 | 37.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 20 | $120.00 | $16.91 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 226 | 464 | $90,480 | $43,686 | 48.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 139 | 187 | $32,725 | $16,423 | 50.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 143 | 240 | $39,600 | $15,780 | 39.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 55 | 98 | $36,750 | $12,858 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 107 | 107 | $27,285 | $12,133 | 44.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 130 | 178 | $20,470 | $6,932 | 33.9% |
About David Cotter, MD, PHD
David Cotter, MD, PHD is a Dermatology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1821482373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Cotter, MD, PHD has received a total of $703,353 in payments from pharmaceutical and medical device companies, with $366,331 received in 2024. These payments were reported across 1,759 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($504,904).
As a Medicare-enrolled provider, Cotter has provided services to 4,750 Medicare beneficiaries, totaling 9,622 services with total Medicare billing of $620,197. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Las Vegas, NV
- Active Since 03/23/2015
- Last Updated 08/24/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1821482373
Products in Payments
- RINVOQ (Biological) $201,015
- SKYRIZI (Biological) $111,600
- DUPIXENT (Biological) $91,698
- AKLIEF (Drug) $47,236
- ADBRY (Biological) $38,003
- SPEVIGO (Drug) $36,915
- Sotyktu (Drug) $28,987
- Zoryve (Drug) $11,372
- COSENTYX (Drug) $11,284
- CIBINQO (Drug) $9,197
- AMZEEQ (Drug) $7,805
- VTAMA (Drug) $7,606
- HUMIRA (Biological) $6,039
- Bimzelx (Biological) $4,351
- ORACEA (Drug) $3,893
- TREMFYA (Drug) $2,880
- EPIDUO FORTE (Drug) $2,716
- EUCRISA (Drug) $907.68
- Otezla (Drug) $872.81
- COSENTYX (Biological) $866.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Las Vegas
Mrs. Miriam Bettencourt, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Harry Greenberg, Md, MD
Dermatology — Payments: $970,450
Dermatology $970,450
Dr. Robert Strimling, Md, MD
Dermatology — Payments: $76,428
Dermatology $76,428
Dr. Candace Spann, M.d, M.D
Dermatology — Payments: $26,803
Dermatology $26,803
Dr. Clifton Hall, M.d, M.D
Dermatology — Payments: $17,129
Dermatology $17,129
Ms. Susun Michaels, Do, DO
Dermatology — Payments: $14,336
Dermatology $14,336